Acupuncture Provides Significant Quality of Life
Improvements Among Breast Cancer Patients Taking Drugs to Prevent Recurrence,
Penn Study Shows
PHILADELPHIA — Use of
electroacupuncture (EA) – a form of acupuncture where a small electric current
is passed between pairs of acupuncture needles – produces significant
improvements in fatigue, anxiety and depression in as little as eight weeks for
early stage breast cancer patients experiencing joint pain related to the use
of aromatase inhibitors (AIs) to treat breast cancer. The results of a
randomized, placebo-controlled trial examining the intervention led by researchers
at the Perelman
School of Medicine at the University of Pennsylvania are published
online this week in the journal Cancer. The study is the first demonstration
of EA’s efficacy for both joint pain relief, as well as these other common
symptoms.
The results build upon earlier findings reported in November 2013,
showing that EA can decrease the joint pain reported by roughly 50 percent of
breast cancer patients taking AIs – the most-commonly prescribed medications to
prevent disease recurrence among post-menopausal women with early-stage,
hormone receptor positive breast cancer. Despite their efficacy, the joint pain
associated with the use of AIs often leads to fatigue, anxiety, depression, and
sleep disturbances for these patients, which researchers suggest may cause
premature discontinuation of the drug. Previous studies have shown that nearly
half of women taking AIs do not complete their recommended course of treatment,
and that those who stop taking the drugs or don’t take them as prescribed have
a higher chance of dying of both breast cancer and other causes.
“Since many patients experience
pain, fatigue, anxiety and depression simultaneously, our results provide an
opportunity to offer patients one treatment that may target multiple symptoms,”
said lead author Jun Mao, MD MSCE, associate professor of Family
Medicine and Community Health in Penn’s Perelman School of Medicine, who
directs the Integrative Oncology program in the Abramson Cancer Center. “We see
patients every day who are looking for ways to combat some of the side effects
of their treatment. What is particularly significant about these new results is
that we can now offer more evidence-based treatment and management solutions
for these women.
In the eight-week trial, researchers
evaluated the short-term effects and safety of EA for AI-related joint pain and
other side effects, compared with sham acupuncture (SA – a non-electric,
placebo acupuncture where the needles are not actually inserted into the skin),
and usual care. The study participants, who were all receiving AI therapy and
experiencing joint pain, were randomly assigned to receive EA, SA or usual
care. Patient-reported experiences of fatigue and psychological distress, were
measured prior to the study, and periodically throughout the duration, with
additional follow-up four weeks after treatment.
- Fatigue: Compared with usual care, patients receiving EA had a greater reduction in the fatigue score at week eight and the effect was maintained at week 12. On average, patients reported a 2.0 point reduction in fatigue on the Brief Fatigue Inventory, an instrument designed to assess fatigue severity on a numerical scale ranging from 0-10.
- Anxiety: By week 12, patients receiving EA reported a significant improvement in their anxiety score, whereas patients receiving SA did not. On average, patients in the EA group reported a 2.2 point reduction in anxiety on the Hospital Anxiety and Depression Scale (HADS) compared to the usual care group.
- Depression: Patients in both EA and SA groups reported a significant improvement in HADS-Depression scores (2.4 points and 2.0 points, respectively) compared with the usual care group by week eight. The effects of both EA and SA on depression were maintained at week 12.
“Our study provides a novel
understanding of how fatigue, sleep and psychological distress relate to pain
in patients with AI-related joint pain. More importantly, we found that
acupuncture helped reduce these symptoms and the effects persisted for at least
four weeks following treatment,” said Mao. “There is a small but growing body
of literature showing that acupuncture is effective for the management of pain,
fatigue, anxiety and depression. However, studies with larger sample sizes and
longer follow-up periods are needed to provide more in-depth knowledge about
how these treatments, combined with usual care, are improving quality of life
for our patients.”
Source of the report is here.
No comments:
Post a Comment